Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer

被引:7
|
作者
Al-Obeidi, Ebaa [1 ]
Riess, Jonathan W. [1 ]
Malapelle, Umberto [2 ]
Rolfo, Christian [3 ]
Gandara, David R. [1 ]
机构
[1] Univ Calif Davis, Div Hematol Oncol, 4501 10 St,Suite 3016, Sacramento, CA 95817 USA
[2] Univ Naples Federico II, Dept Publ Hlth, Via Sergio Pansini 5, I-80131 Naples, Italy
[3] Icahn Sch Med Mt Sinai, Ctr Thorac Oncol, Tisch Canc Inst, One Gustave Levy Pl,Box 1079, New York, NY 10029 USA
关键词
Liquid biopsy; Circulating tumor DNA (ctDNA); Next-generation sequencing (NGS); Minimal residual disease (MRD); Tumor mutational burden (TMB); Non-small cell lung cancer (NSCLC); CIRCULATING TUMOR DNA; RESIDUAL DISEASE; CLINICAL UTILITY; RESISTANCE; LANDSCAPE; BLOCKADE;
D O I
10.1016/j.hoc.2023.02.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [21] An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer
    Mayo-de-Las-Casas, Clara
    Garzon Ibanez, Monica
    Jordana-Ariza, Nuria
    Garcia-Pelaez, Beatriz
    Balada-Bel, Ariadna
    Villatoro, Sergio
    Malapelle, Umberto
    Karachaliou, Niki
    Troncone, Giancarlo
    Rosell, Rafael
    Angel Molina-Vila, Miguel
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (01) : 35 - 45
  • [22] Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Nagasaka, Misako
    Uddin, Mohammed Hafiz
    Al-Hallak, Mohammed Najeeb
    Rahman, Sarah
    Balasubramanian, Suresh
    Sukari, Ammar
    Azmi, Asfar S.
    MOLECULAR CANCER, 2021, 20 (01)
  • [23] Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi, Can
    Zhang, Ming-feng
    Peng, Xiao-xiao
    Zhang, Yi-chen
    Xu, Chong-rui
    Zhou, Qing
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (12) : 1089 - 1096
  • [24] Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
    Huang, Lanxiang
    Rong, Yuan
    Tang, Xuan
    Yi, Kezhen
    Wu, Jianyuan
    Wang, Fubing
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [25] Update on liquid biopsy in clinical management of non-small cell lung cancer
    Wu, Zhen
    Yang, Zhen
    Dai, Yu
    Zhu, Qiang
    Chen, Liang-An
    ONCOTARGETS AND THERAPY, 2019, 12 : 5097 - 5109
  • [26] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Zhang, Yi-Chen
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [27] EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia
    Cavic, Milena
    Krivokuca, Ana
    Pavlovic, Marijana
    Boljevic, Ivana
    Rakobradovic, Jelena
    Mihajlovic, Milica
    Tanic, Miljana
    Damjanovic, Ana
    Malisic, Emina
    Jankovic, Radmila
    JOURNAL OF BUON, 2020, 25 (06): : 2635 - 2642
  • [28] Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared
    Manicone, Mariangela
    Scaini, Maria Chiara
    Rodriquenz, Maria Grazia
    Facchinetti, Antonella
    Tartarone, Alfredo
    Aieta, Michele
    Zamarchi, Rita
    Rossi, Elisabetta
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1391 - S1396
  • [29] Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
    Bonanno, Laura
    Dal Maso, Alessandro
    Pavan, Alberto
    Zulato, Elisabetta
    Calvetti, Lorenzo
    Pasello, Giulia
    Guarneri, Valentina
    Conte, PierFranco
    Indraccolo, Stefano
    BRITISH JOURNAL OF CANCER, 2022, 127 (03) : 383 - 393
  • [30] Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
    Shen, Haifeng
    Jin, Yichen
    Zhao, Heng
    Wu, Manqi
    Zhang, Kai
    Wei, Zihan
    Wang, Xin
    Wang, Ziyang
    Li, Yun
    Yang, Fan
    Wang, Jun
    Chen, Kezhong
    BMC MEDICINE, 2022, 20 (01)